Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
基本信息
- 批准号:7261173
- 负责人:
- 金额:$ 12.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-15 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressBiliaryBiliary AtresiaBinding SitesBiological AssayCCL2 geneCell LineCell surfaceCellsCellular ImmunityCessation of lifeChildChildhoodCholestasisClinicalCoupledDevelopmentDiseaseEpithelial CellsEventExperimental ModelsFlow CytometryFutureGene ActivationGenesGenomeHepaticImmune responseIn VitroInbred BALB C MiceInfantInfectionInflammatoryInflammatory ResponseInjuryIntegrinsLigandsLiverLiver diseasesLuciferasesMacaca mulattaMeasuresMessenger RNAMiningModelingMolecularMonoclonal AntibodiesMononuclearMusNF-kappa BNeonatalNewborn InfantNumbersOperative Surgical ProceduresPathogenesisPathway interactionsPatientsPeptidesPhenotypePlayPredispositionProcessProductionPromoter RegionsPropertyProteinsRANTESRNA InterferenceReporterResearch DesignResearch PersonnelRoleRotavirusRotavirus InfectionsSamplingSequence AnalysisSignal Transduction PathwaySourceStagingTestingTherapeuticTropismViralViral PathogenesisVirusVirus DiseasesWestern Blottingbasebiliary tractchemokinecholangiocyteconceptdesignenvironmental agentfunctional genomicsgel mobility shift assaygenetic elementin vitro Modelin vivoinhibitor/antagonistinsightliver transplantationmouse modelnovelprogramsreceptorreconstructiontranscription factor
项目摘要
DESCRIPTION (provided by applicant):
Biliary atresia is the most common cause of neonatal cholestasis and if untreated results in end-stage liver disease (ESLD) and death. Even with current treatment strategies most children develop progressive liver disease and require liver transplantation for salvage. Biliary atresia is the number one indication for pediatric liver transplantation. Despite its importance, the pathogenesis of biliary atresia is unknown. One possible cause is an infection by an environmental agents such as viruses in a susceptible host. We established an experimental mouse model of biliary atresia and found that biliary injury in mice could be induced by a specific rotavirus species - rhesus rotavirus (RRV) in a susceptible murine host - BALB/c mice that progresses to ESLD and death. The inflammatory cholangiopathy is initiated at the biliary epithelial cell level and mirrors the disease process that is found in infants. This model will be used to define the molecular mechanisms regulating the interaction between a virus and the biliary system testing the over-arching hypothesis that the biliary atresia results from the abnormal recognition and infection of biliary epithelial cells (cholangiocytes) by a virus. This hypothesis will be addressed by the following specific aims: 1) Determine the specific RRV gene(s) necessary for the induction of biliary atresia in mice. 2) Determine the mechanism by which the cholangicoyte is susceptible to RRV infection. 3) Determine the mechanism by which RRV infected cholangiocytes triggers a host inflammatory response. The rotavirus property of gene reassortment will be used to identify the RRV gene(s) that cause the murine model of biliary atresia. A novel in vitro model in which RRV is able to infect a cholangiocyte cell line will be used to identify the mechanism by which RRV infects the cholangicoyte. Flow cytometry was used to detect the presence of the integrin apha2beta1 known to confer vulnerabiity to rotavirus infection. Blocking studies using natural ligands and monoclonal antibodies against this protein will be performed to determine its role. In vitro, cholangiocytes infected by RRV produce chemokines. This may be the triggering mechanism by which the host inflammatory response is initiated. We will determine if a similar process occurs in vivo. We will also determine if the NF-kappaB intracellular pathway is the mechansim by which RRV infection induces chemokine production.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY M TIAO其他文献
GREGORY M TIAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY M TIAO', 18)}}的其他基金
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
- 批准号:
8085527 - 财政年份:2011
- 资助金额:
$ 12.58万 - 项目类别:
Genetic basis of virus induced Biliary Atresia
病毒引起的胆道闭锁的遗传基础
- 批准号:
10328541 - 财政年份:2011
- 资助金额:
$ 12.58万 - 项目类别:
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
- 批准号:
8449192 - 财政年份:2011
- 资助金额:
$ 12.58万 - 项目类别:
The Molecular Determinants of Virus Induced Biliary Atresia
病毒引起的胆道闭锁的分子决定因素
- 批准号:
8243504 - 财政年份:2011
- 资助金额:
$ 12.58万 - 项目类别:
Intracellular signaling pathways and virus induced biliary atresia
细胞内信号通路与病毒诱导的胆道闭锁
- 批准号:
7875916 - 财政年份:2010
- 资助金额:
$ 12.58万 - 项目类别:
Intracellular signaling pathways and virus induced biliary atresia
细胞内信号通路与病毒诱导的胆道闭锁
- 批准号:
8051858 - 财政年份:2010
- 资助金额:
$ 12.58万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
6961713 - 财政年份:2005
- 资助金额:
$ 12.58万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
7121806 - 财政年份:2005
- 资助金额:
$ 12.58万 - 项目类别:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
病毒性胆道闭锁的发病机制
- 批准号:
7637736 - 财政年份:2005
- 资助金额:
$ 12.58万 - 项目类别:
INTRAVENOUS METHYLPREDNISOLONE VS ORAL PREDNISOLONE IN TRANSPLANT REJECTION
静脉注射甲基泼尼松龙与口服泼尼松龙在移植排斥中的比较
- 批准号:
7374506 - 财政年份:2005
- 资助金额:
$ 12.58万 - 项目类别:
相似海外基金
Modeling genetic contributions to biliary atresia
模拟遗传对胆道闭锁的影响
- 批准号:
10639240 - 财政年份:2023
- 资助金额:
$ 12.58万 - 项目类别:
Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia
胆道闭锁表型和临床结果的生物学基础
- 批准号:
10824147 - 财政年份:2023
- 资助金额:
$ 12.58万 - 项目类别:
Elucidation of the etiology and pathogenesis of biliary atresia by comprehensive search for lipid-soluble metabolites in stool
综合寻找粪便中脂溶性代谢物阐明胆道闭锁的病因和发病机制
- 批准号:
21K16376 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a New Method of Bilirubin Screening for Biliary Atresia
胆红素筛查胆道闭锁新方法的评价
- 批准号:
10194633 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:
Evaluation of a New Method of Bilirubin Screening for Biliary Atresia
胆红素筛查胆道闭锁新方法的评价
- 批准号:
10379379 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:
Macrophage Regulation of Immune Pathogenesis of Biliary Atresia
巨噬细胞对胆道闭锁免疫发病机制的调节
- 批准号:
10543779 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:
Macrophage Regulation of Immune Pathogenesis of Biliary Atresia
巨噬细胞对胆道闭锁免疫发病机制的调节
- 批准号:
10761123 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:
Development of novel therapies for biliary atresia using bile duct organoids
使用胆管类器官开发胆道闭锁的新疗法
- 批准号:
21K16406 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Macrophage Regulation of Immune Pathogenesis of Biliary Atresia
巨噬细胞对胆道闭锁免疫发病机制的调节
- 批准号:
10320943 - 财政年份:2021
- 资助金额:
$ 12.58万 - 项目类别:














{{item.name}}会员




